Literature DB >> 21142436

Heart failure with preserved left ventricular ejection fraction: concepts, misconceptions and future directions.

Johannes Soma1.   

Abstract

Heart failure with preserved left ventricular ejection fraction (HFPEF) represents a huge medical problem, especially in light of an increasing elderly population. Dysfunction of both left ventricular filling and ejection, combined with adverse loading conditions related to advanced age, arterial hypertension, diabetes mellitus, obesity and atrial fibrillation are fundamental pathophysiological mechanisms. Hypertension is probably the most important modifiable risk factor. The diagnosis has largely been based on signs of increased left ventricular filling pressure. Additional matters of debate are the interpretation of left ventricular ejection fraction in concentric remodelling and the cut-off used for the definition of HFPEF, as well as inconsistencies related to prevalence and prognosis, and lack of benefit of drugs in randomized trials.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21142436     DOI: 10.3109/08037051.2010.542642

Source DB:  PubMed          Journal:  Blood Press        ISSN: 0803-7051            Impact factor:   2.835


  3 in total

Review 1.  Heart failure with preserved ejection fraction: emerging drug strategies.

Authors:  Fouad A Zouein; Lisandra E de Castro Brás; Danielle V da Costa; Merry L Lindsey; Mazen Kurdi; George W Booz
Journal:  J Cardiovasc Pharmacol       Date:  2013-07       Impact factor: 3.105

2.  Abnormal calcium homeostasis in heart failure with preserved ejection fraction is related to both reduced contractile function and incomplete relaxation: an electromechanically detailed biophysical modeling study.

Authors:  Ismail Adeniran; David H MacIver; Jules C Hancox; Henggui Zhang
Journal:  Front Physiol       Date:  2015-03-20       Impact factor: 4.566

Review 3.  Heart Failure with Preserved Ejection Fraction - Concept, Pathophysiology, Diagnosis and Challenges for Treatment.

Authors:  Lidija Veterovska Miljkovik; Vera Spiroska
Journal:  Open Access Maced J Med Sci       Date:  2015-07-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.